KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Assets (2016 - 2026)

Quest Diagnostics' Assets history spans 18 years, with the latest figure at $16.7 billion for Q1 2026.

  • On a quarterly basis, Assets rose 5.55% to $16.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $16.7 billion, a 5.55% increase, with the full-year FY2025 number at $16.2 billion, changed 0.45% from a year prior.
  • Assets hit $16.7 billion in Q1 2026 for Quest Diagnostics, up from $16.2 billion in the prior quarter.
  • Over the last five years, Assets for DGX hit a ceiling of $16.7 billion in Q1 2026 and a floor of $12.8 billion in Q1 2023.
  • Historically, Assets has averaged $14.6 billion across 5 years, with a median of $14.0 billion in 2024.
  • Biggest five-year swings in Assets: dropped 5.69% in 2022 and later increased 19.38% in 2024.
  • Tracing DGX's Assets over 5 years: stood at $12.8 billion in 2022, then rose by 9.23% to $14.0 billion in 2023, then grew by 15.2% to $16.2 billion in 2024, then rose by 0.45% to $16.2 billion in 2025, then rose by 2.76% to $16.7 billion in 2026.
  • Business Quant data shows Assets for DGX at $16.7 billion in Q1 2026, $16.2 billion in Q4 2025, and $16.2 billion in Q3 2025.